Viewing StudyNCT00096044



Ignite Creation Date: 2024-05-05 @ 11:38 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00096044
Status: COMPLETED
Last Update Posted: 2017-07-11
First Post: 2004-11-09

Brief Title: Lenalidomide With or Without Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Sponsor: Roswell Park Cancer Institute
Organization: Roswell Park Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Leukemia
Keywords:
Name View
refractory chronic lymphocytic leukemia View